|
TRIM62 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.157200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.219000E-01 |
| Normal-vs-Stage2 |
2.238400E-02 |
| Normal-vs-Stage3 |
1.366160E-01 |
| Normal-vs-Stage4 |
5.230000E-01 |
| Stage1-vs-Stage2 |
4.194200E-02 |
| Stage1-vs-Stage3 |
3.332200E-01 |
| Stage1-vs-Stage4 |
8.973000E-01 |
| Stage2-vs-Stage3 |
1.852560E-01 |
| Stage2-vs-Stage4 |
1.848410E-01 |
| Stage3-vs-Stage4 |
6.634000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.495400E-01 |
| Normal-vs-AfricanAmerican |
2.656800E-01 |
| Normal-vs-Asian |
7.985200E-01 |
| Caucasian-vs-AfricanAmerican |
7.384200E-01 |
| Caucasian-vs-Asian |
8.753800E-01 |
| AfricanAmerican-vs-Asian |
7.785000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.048770E-01 |
| Normal-vs-Female |
7.383000E-01 |
| Male-vs-Female |
5.504300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.801600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.305200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.069600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.721960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.859400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.575400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.469600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.207790E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.237600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.326400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.071440E-01 |
| Normal-vs-Grade 2 |
5.328000E-01 |
| Normal-vs-Grade 3 |
2.363600E-02 |
| Normal-vs-Grade 4 |
8.030800E-01 |
| Grade 1-vs-Grade 2 |
4.904100E-02 |
| Grade 1-vs-Grade 3 |
9.438500E-04 |
| Grade 1-vs-Grade 4 |
6.287800E-02 |
| Grade 2-vs-Grade 3 |
1.450430E-02 |
| Grade 2-vs-Grade 4 |
8.517600E-01 |
| Grade 3-vs-Grade 4 |
1.634760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.723440E-01 |
| Normal-vs-ccB subtype |
3.268000E-01 |
| ccA subtype-vs-ccB subtype |
7.436000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.615400E-01 |
| Normal-vs-N1 |
3.105000E-01 |
| N0-vs-N1 |
6.564000E-01 |
|
|
